(Formerly known as Central Clinical School)
 |
| L-R: First co-authors Drs Jay Jha and Jakob Østergaard, lead author Professor Karin Jandeleit-Dahm, CCS Diabetes |
by Anne Crawford
A study by Monash University Department of Diabetes researchers suggests that a new anti-inflammatory drug approach developed to counter inflammation and heart disease may be harmful to kidneys.
 |
Fasting high blood sugar levels indicate a higher risk of adverse outcomes from COVID-19 infection: Study |
Recent publications featuring research as notified by PubMed during December 2021 - 13 February 2022 from Central Clinical School affiliated researchers in the following departments. The below is not a comprehensive list, there are too many!
The most recent validated publications for the school and departments can be seen on their publications pages, linked to from the headings below. Otherwise, read down the entry for recent notifications. |
This is the largest research investment in MS Australia’s 50-year history, taking the total amount provided for local investigator-led scientific projects in MS to $54 million since the organisation began in 1972.
Monash University researchers received a total of $754,000 in MS Australia’s 2022 round of funding. They included four Central Clinical School (CCS) researchers and one Biomedicine Discovery Institute (BDI) researcher. Congratulations to CCS's Associate Professor Anneke van der Walt, Dr Yi Chao Foong, Dr Daniel Merlo, Dr Steven Petratos, and BDI's Dr Hugh Reid!
 |
| Dr Dan So is lead author on a paper which is the first to test sugar-cane fibres for IBS patients on a low FODMAP diet. Link |
A low FODMAP diet is used to manage symptoms in Irritable Bowel Syndrome (IBS) but does not typically improve bowel habits. Specific types of fibre can improve bowel habits, but their tolerability in IBS and the suitability of coadministration with a low FODMAP diet is unknown.
Dr Daniel So recently completed his PhD in the Central Clinical School's Department of Gastroenterology, and now works with Atmo Biosciences in addition to being an affiliate research dietitian in the department. His PhD explored how specific types of dietary fibre could be used to provide clinical value in patients with IBS.
Dr So is lead author on this paper, the first to evaluate the benefit that a novel fibre, sugarcane bagasse, could offer to patients with IBS, as an adjunct to a low FODMAP diet.
 |
| A/Prof Joe Doyle |
Congratulations to Associate Professor Joseph Doyle, who has been appointed to a newly formed Independent Pandemic Management Advisory Committee (IPMAC), for his expertise in infectious diseases and public health. A/Prof Doyle has joint appointments with Burnet Institute, Alfred Health and Monash University.
The IPMAC – formally established by the Victorian Minister for Health, Martin Foley and announced 15 Feb – will include members with knowledge and experience in fields such as public health, infectious diseases, primary care, emergency services, critical care, business, law and human rights.
